Cargando…

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

Drug resistance of cancer cells is recognized as the primary cause of failure of chemotherapeutic treatment in most human cancers. Growing evidences support the idea that deregulated cellular metabolism is linked to such resistance. Indeed, both components of the glycolytic and mitochondrial pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ippolito, Luigi, Marini, Alberto, Cavallini, Lorenzo, Morandi, Andrea, Pietrovito, Laura, Pintus, Gianfranco, Giannoni, Elisa, Schrader, Thomas, Puhr, Martin, Chiarugi, Paola, Taddei, Maria Letizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308698/ https://www.ncbi.nlm.nih.gov/pubmed/27542265 http://dx.doi.org/10.18632/oncotarget.11301

Ejemplares similares

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression
por: Pietrovito, Laura, et al.
Publicado: (2020)

Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells
por: Taddei, Maria Letizia, et al.
Publicado: (2014)

Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
por: Taddei, Maria Letizia, et al.
Publicado: (2020)

Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts
por: Comito, Giuseppina, et al.
Publicado: (2016)

Globular Adiponectin Activates Motility and Regenerative Traits of Muscle Satellite Cells
por: Fiaschi, Tania, et al.
Publicado: (2012)

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
por: Giannoni, Elisa, et al.
Publicado: (2015)

Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
por: Ippolito, Luigi, et al.
Publicado: (2020)

Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits
por: Calvani, Maura, et al.
Publicado: (2016)

Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness
por: Taddei, Maria Letizia, et al.
Publicado: (2012)

Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition
por: Pietrovito, Laura, et al.
Publicado: (2018)

Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion
por: Chiarugi, Paola, et al.
Publicado: (2003)

The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
por: Margheri, Francesca, et al.
Publicado: (2014)

Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
por: Calvani, Maura, et al.
Publicado: (2014)

Glucose Metabolic Reprogramming of ER(+) Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib
por: Lorito, Nicla, et al.
Publicado: (2020)

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer
por: Gruber, Martina, et al.
Publicado: (2020)

Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species
por: Calvani, Maura, et al.
Publicado: (2012)

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment
por: Martellucci, Stefano, et al.
Publicado: (2021)

Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells
por: Leo, Angela, et al.
Publicado: (2021)

Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
por: Iozzo, Marta, et al.
Publicado: (2021)

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
por: Kroon, Jan, et al.
Publicado: (2016)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)

Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation
por: Doldi, Valentina, et al.
Publicado: (2015)

The role of epithelial–mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel‐resistant prostate cancer
por: Hanrahan, Karen, et al.
Publicado: (2017)

PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells
por: Puhr, Martin, et al.
Publicado: (2014)

5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits
por: Denise, Corti, et al.
Publicado: (2015)

Nutritional Exchanges Within Tumor Microenvironment: Impact for Cancer Aggressiveness
por: Comito, Giuseppina, et al.
Publicado: (2020)

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies
por: Sanna, Vanna, et al.
Publicado: (2011)

The Prostate Cancer Cells Resistant to Docetaxel as in vitro Model for Discovering MicroRNAs Predictive of the Onset of Docetaxel Resistance
por: Bascetta, Lorenzo, et al.
Publicado: (2017)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer
por: Bacci, Marina, et al.
Publicado: (2019)

Globular Adiponectin as a Complete Mesoangioblast Regulator: Role in Proliferation, Survival, Motility, and Skeletal Muscle Differentiation
por: Fiaschi, Tania, et al.
Publicado: (2010)

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
por: Pardella, Elisa, et al.
Publicado: (2022)

Molecular mechanisms of docetaxel resistance in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2020)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
por: Francini, Filippo, et al.
Publicado: (2011)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
por: Omoboyede, Victor, et al.
Publicado: (2023)

Small ankyrin 1 (sANK1) promotes docetaxel resistance in castration‐resistant prostate cancer cells by enhancing oxidative phosphorylation
por: Yang, Yang, et al.
Publicado: (2022)

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer
por: Keresztes, Dávid, et al.
Publicado: (2021)

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe
por: Drápela, Stanislav, et al.
Publicado: (2020)

Vibrational Study on Structure and Bioactivity of Protein Fibers Grafted with Phosphorylated Methacrylates
por: Di Foggia, Michele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_23tscjj18ihllp87m4a0qhqclg